LBP and obesity due to melanocortin 4 receptor deficiency: A. muciniphila levels are inversely associated to obesity and diabetes (181, 182) and its administration reduced body weight and metabolic inflammation by reducing plasma lipopolysaccharide (LPS)-binding protein (LBP) and leptin, as well as inactivated LPS/LBP downstream signaling (182, 183).